The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
D000005:Abdomen; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002490:Central Nervous System / Q000187:drug effects; D002750:Chlorquinaldol / Q000009:adverse effects; D007464:Clioquinol / Q000009:adverse effects; D004196:Disease Outbreaks; D004305:Dose-Response Relationship, Drug; D006801:Humans; D004103:Iodoquinol / Q000009:adverse effects; D007564:Japan; D009187:Myelitis / Q000139:chemically induced*; D009461:Neurologic Manifestations; D009902:Optic Neuritis / Q000139:chemically induced*; D010146:Pain / Q000139:chemically induced; D011804:Quinolines / Q000009:adverse effects*; D013577:Syndrome; D013997:Time Factors
D000890:Anti-Infective Agents; D011804:Quinolines; D004103:Iodoquinol; D007464:Clioquinol; D002750:Chlorquinaldol